BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 28191815)

  • 1. Bladder cancer cell growth and motility implicate cannabinoid 2 receptor-mediated modifications of sphingolipids metabolism.
    Bettiga A; Aureli M; Colciago G; Murdica V; Moschini M; Lucianò R; Canals D; Hannun Y; Hedlund P; Lavorgna G; Colombo R; Bassi R; Samarani M; Montorsi F; Salonia A; Benigni F
    Sci Rep; 2017 Feb; 7():42157. PubMed ID: 28191815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of the CB
    Khan MI; Sobocińska AA; Brodaczewska KK; Zielniok K; Gajewska M; Kieda C; Czarnecka AM; Szczylik C
    BMC Cancer; 2018 May; 18(1):583. PubMed ID: 29792186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabinoid receptors, CB1 and CB2, as novel targets for inhibition of non-small cell lung cancer growth and metastasis.
    Preet A; Qamri Z; Nasser MW; Prasad A; Shilo K; Zou X; Groopman JE; Ganju RK
    Cancer Prev Res (Phila); 2011 Jan; 4(1):65-75. PubMed ID: 21097714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Granulocyte Colony-Stimulating Factor Enhances Brain Repair Following Traumatic Brain Injury Without Requiring Activation of Cannabinoid Receptors.
    Song S; Kong X; Borlongan C; Sava V; Sanchez-Ramos J
    Cannabis Cannabinoid Res; 2021; 6(1):48-57. PubMed ID: 33614952
    [No Abstract]   [Full Text] [Related]  

  • 5. Cannabinoid receptor activation induces apoptosis through tumor necrosis factor alpha-mediated ceramide de novo synthesis in colon cancer cells.
    Cianchi F; Papucci L; Schiavone N; Lulli M; Magnelli L; Vinci MC; Messerini L; Manera C; Ronconi E; Romagnani P; Donnini M; Perigli G; Trallori G; Tanganelli E; Capaccioli S; Masini E
    Clin Cancer Res; 2008 Dec; 14(23):7691-700. PubMed ID: 19047095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabinoid CB
    Olianas MC; Dedoni S; Onali P
    Life Sci; 2021 Jul; 276():119407. PubMed ID: 33794254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of cannabinoid 1 and, 2 receptors and the effects of cannabinoid 1 and, 2 receptor agonists on detrusor overactivity associated with bladder outlet obstruction in rats.
    Kim SD; Cho KJ; Kim JC
    BMC Urol; 2017 Dec; 17(1):121. PubMed ID: 29284441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabinoid receptor expression in non-small cell lung cancer. Effectiveness of tetrahydrocannabinol and cannabidiol inhibiting cell proliferation and epithelial-mesenchymal transition in vitro.
    Milian L; Mata M; Alcacer J; Oliver M; Sancho-Tello M; Martín de Llano JJ; Camps C; Galbis J; Carretero J; Carda C
    PLoS One; 2020; 15(2):e0228909. PubMed ID: 32049991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of ERK1/2, cPLA2 and NF-κB in microglia suppression by cannabinoid receptor agonists and antagonists.
    Ribeiro R; Wen J; Li S; Zhang Y
    Prostaglandins Other Lipid Mediat; 2013 Jan; 100-101():1-14. PubMed ID: 23219970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of cannabinoid receptors type 1 and type 2 in non-Hodgkin lymphoma: growth inhibition by receptor activation.
    Gustafsson K; Wang X; Severa D; Eriksson M; Kimby E; Merup M; Christensson B; Flygare J; Sander B
    Int J Cancer; 2008 Sep; 123(5):1025-33. PubMed ID: 18546271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opposite effects of cannabinoid CB
    Li L; Dong X; Tu C; Li X; Peng Z; Zhou Y; Zhang D; Jiang J; Burke A; Zhao Z; Jin L; Jiang Y
    Br J Pharmacol; 2019 Apr; 176(7):890-905. PubMed ID: 30707759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabinoid receptor agonists upregulate and enhance serotonin 2A (5-HT(2A)) receptor activity via ERK1/2 signaling.
    Franklin JM; Carrasco GA
    Synapse; 2013 Mar; 67(3):145-59. PubMed ID: 23151877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Cannabinoid Agonists and Antagonists on Sleep and Breathing in Sprague-Dawley Rats.
    Calik MW; Carley DW
    Sleep; 2017 Sep; 40(9):. PubMed ID: 28934522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabinoid receptor agonists and antagonists stimulate insulin secretion from isolated human islets of Langerhans.
    Li C; Bowe JE; Huang GC; Amiel SA; Jones PM; Persaud SJ
    Diabetes Obes Metab; 2011 Oct; 13(10):903-10. PubMed ID: 21564460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of cannabinoid receptors in hepatic fibrosis and apoptosis associated with bile duct ligation in rats.
    Mahmoud MF; Swefy SE; Hasan RA; Ibrahim A
    Eur J Pharmacol; 2014 Nov; 742():118-24. PubMed ID: 25179573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CB2 cannabinoid receptors promote mouse neural stem cell proliferation.
    Molina-Holgado F; Rubio-Araiz A; García-Ovejero D; Williams RJ; Moore JD; Arévalo-Martín A; Gómez-Torres O; Molina-Holgado E
    Eur J Neurosci; 2007 Feb; 25(3):629-34. PubMed ID: 17328768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cannabinoid delta(9)-tetrahydrocannabinol inhibits RAS-MAPK and PI3K-AKT survival signalling and induces BAD-mediated apoptosis in colorectal cancer cells.
    Greenhough A; Patsos HA; Williams AC; Paraskeva C
    Int J Cancer; 2007 Nov; 121(10):2172-80. PubMed ID: 17583570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of phosphoinositide 3-kinase/PKB pathway by CB(1) and CB(2) cannabinoid receptors expressed in prostate PC-3 cells. Involvement in Raf-1 stimulation and NGF induction.
    Sánchez MG; Ruiz-Llorente L; Sánchez AM; Díaz-Laviada I
    Cell Signal; 2003 Sep; 15(9):851-9. PubMed ID: 12834810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabinoid receptors CB1 and CB2 form functional heteromers in brain.
    Callén L; Moreno E; Barroso-Chinea P; Moreno-Delgado D; Cortés A; Mallol J; Casadó V; Lanciego JL; Franco R; Lluis C; Canela EI; McCormick PJ
    J Biol Chem; 2012 Jun; 287(25):20851-65. PubMed ID: 22532560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Up-regulation of immunomodulatory effects of mouse bone-marrow derived mesenchymal stem cells by tetrahydrocannabinol pre-treatment involving cannabinoid receptor CB2.
    Xie J; Xiao D; Xu Y; Zhao J; Jiang L; Hu X; Zhang Y; Yu L
    Oncotarget; 2016 Feb; 7(6):6436-47. PubMed ID: 26824325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.